Excerpted from Reuters.com, Friday, 27 September 2002.

NEW YORK (Reuters) - September 27, 2002 - Wyeth (WYE.N) said on Friday it may have to take additional reserves in the future to pay for litigation related to its recalled diet-drug cocktail fen-phen.

Wyeth, formerly known as American Home Products, in recent years had to pay billions of dollars to former users of two diet drugs once included in the "fen-phen" slimming cocktail, to settle lawsuits alleging the drugs caused heart damage.

Chief Financial Officer Kenneth Martin told analysts and investors on a conference call Friday that Wyeth will take an additional reserve of $1.4 billion in addition to the $13.2 billion the firm has already taken to cover litigation.

He said it is difficult to calculate reserves as additional patients emerge, adding "possible additional reserves may be required."

The company cut earnings forecasts for the year due in part to slowing sales of its flagship hormone replacement products after prominent medical journal articles questioned the safety of the drugs.

Excerpted from Reuters.com, Friday, 27 September 2002.